Familial evaluation in arrhyth- mogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria. Circulation. 2011;123:2701 9. S4.2.6-16. Rigato I, Bauce B, Rampazzo A, et al. Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet. 2013;6:533 42. S4.2.6-17. Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consen- sus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partner- ship between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace. 2011;13:1077 109. S4.2.6-18. Gollob MH, Blier L, Brugada R, et al. Recommendations for the use of genetic testing in the clinical evaluation of inherited car- diac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint posi- tion paper. Can J Cardiol. 2011;27:232 45. S4.2.6-19. Kumar S, Peters S, Thompson T, et al. Familial cardiological and tar- geted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes. Heart Rhythm. 2013;10:1653 60. S4.2.6-20. Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013;10:1932 63. S4.2.6-21. Tester DJ, Medeiros-Domingo A, Will ML, et al. Unexplained drown- ings and the cardiac channelopathies: a molecular autopsy series. Mayo Clin Proc. 2011;86:941 7. S4.2.6-22. Tzimas I, Zingraf JC, Bajanowski T, et al. The role of known variants deaths. Int J Legal Med. 2016;130:1575 9. S4.2.6-23. Wang D, Shah KR, Um SY, et al. Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths. Forensic Sci Int. 2014;237:90 9. S4.2.6-24. Laedtke AL, O Neill SM, Rubinstein WS, et al. 